February 15, 2017 | Denise Heady
City of Hope case study published in the New England Journal of Medicine reported treatment with reengineered CAR-T cells dramatically improved quality of life for patient with recurrent glioblastoma.
June 27, 2017 | Samantha Bonar
Bart O. Roep, Ph.D., has dedicated his life to the search for a cure for type 1 diabetes. And he thinks he is on the brink. Roep, an internationally renowned immunologist who joined City of Hope last year from the Netherlands’ Leiden University Medical Center, was recently named the Chan Soon-Shiong Shapiro Distinguished Chair in Diabetes. He believes that this endowment and a $50 million funding project led by the Wanek family will be key in stopping the disease.
June 2, 2017 | Letisia Marquez
City of Hope physicians and researchers are headed to Chicago to present groundbreaking research on blood stem cell transplants for HIV patients, immunotherapies, unique treatment options for older adults battling breast cancer and other topics during the American Society of Clinical Oncology’s (ASCO) 2017 Annual Meeting June 2 to 6.
May 24, 2017 | City of Hope
Genetically targeted therapies are becoming standard in cancer therapy and clinicians at City of Hope are pioneering liquid biopsy, a new noninvasive way of obtaining samples to make strategic therapeutic decisions with less discomfort, and less risk to patients.
May 18, 2017 | Katie Neith
Using a simple but unique approach to image bladder cancer cells called Cysview, physicians at City of Hope are getting a better look at tumors and other abnormalities within the organ.
May 16, 2017 | Abe Rosenberg
Bladder cancer is a stubborn disease. But the City of Hope surgeons and scientists working to eradicate bladder cancer are equally stubborn.
April 25, 2017 | City of Hope
Our team of clinical specialists and researchers are pioneering innovative treatments for pediatric cancer and childhood diseases, including advances in gene therapy, immunotherapy and targeted therapy.
April 3, 2017 | Travis Marshall
An upcoming phase 1 clinical trial at City of Hope will look at the effects of CAR-T cells programmed to target a protein called CS-1, which is found on myeloma cells.
April 1, 2017 | City of Hope
Studies address a variety of challenges in cancer treatment and research.
March 29, 2017 | Katie Neith
City of Hope scientists believe they have found a key mechanism for potentially keeping prostate cancer at bay, both before and after diagnosis.
March 28, 2017 | Michael Easterling
Patients who have benefited from stem cell therapies funded by CIRM were the focus of the second symposium of the Alpha Stem Cell Clinics Network.